Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial (Expression of Concern of Vol 84, Pg 851, 2015)

被引：1

|

作者：

不详

机构：

来源：

CLINICAL ENDOCRINOLOGY | 2023年 / 98卷 / 05期

关键词：

D O I：

10.1111/cen.14891

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：745 / 745

页数：1

相关论文

共 50 条

[1] Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial (Publication with Expression of Concern. See FEB, 2023)
Samimi, Mansooreh
Jamilian, Mehri
Ebrahimi, Faraneh Afshar
Rahimi, Maryam
Tajbakhsh, Banafsheh
Asemi, Zatollah
CLINICAL ENDOCRINOLOGY, 2016, 84 (06) : 851 - 857
[2] Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial (Expression of Concern of Vol 67, Pg 42, 2015)
不详
ANNALS OF NUTRITION AND METABOLISM, 2023,
[3] Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial (Publication with Expression of Concern)
Jamilian, Mehri
Foroozanfard, Fatemeh
Kavossian, Elham
Kia, Mersedeh
Aghadavod, Esmat
Amirani, Elaheh
Asemi, Zatollah
BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 193 (02) : 334 - 341
[4] Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial (Publication with Expression of Concern)
Jamilian, Mehri
Foroozanfard, Fatemeh
Bahmani, Fereshteh
Talaee, Rezvan
Monavari, Mahshid
Asemi, Zatollah
BIOLOGICAL TRACE ELEMENT RESEARCH, 2016, 170 (02) : 271 - 278
[5] Effects of Zinc Supplementation on Markers of Insulin Resistance and Lipid Profiles in Women with Polycystic Ovary Syndrome: a Randomized, Double-blind, Placebo-controlled Trial
Foroozanfard, F.
Jamilian, M.
Jafari, Z.
Khassaf, A.
Hosseini, A.
Khorammian, H.
Asemi, Z.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2015, 123 (04) : 215 - 220
[6] Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial (Publication with Expression of Concern)
Ahmadi, Shahnaz
Jamilian, Mehri
Karamali, Maryam
Tajabadi-Ebrahimi, Maryam
Jafari, Parvaneh
Taghizadeh, Mohsen
Memarzadeh, Mohammad Reza
Asemi, Zatollah
HUMAN FERTILITY, 2017, 20 (04) : 254 - 261
[7] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
Jamilian, M.
CLINICAL ENDOCRINOLOGY, 2024, 100 (06) : 593 - 593
[8] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Jamilian, Mehri
Razavi, Maryamalsadat
Kashan, Zohreh Fakhrie
Ghandi, Yasser
Bagherian, Tayebeh
Asemi, Zatollah
CLINICAL ENDOCRINOLOGY, 2015, 82 (06) : 885 - 891
[9] Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
Mehri Jamilian
Fatemeh Foroozanfard
Elham Kavossian
Mersedeh Kia
Esmat Aghadavod
Elaheh Amirani
Zatollah Asemi
Biological Trace Element Research, 2020, 193 : 334 - 341
[10] Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Jamilian, Hamidreza
Jamilian, Mehri
Samimi, Mansooreh
Ebrahimi, Faraneh Afshar
Rahimi, Maryam
Bahmani, Fereshteh
Aghababayan, Sama
Kouhi, Mobina
Shahabbaspour, Sedighe
Asemi, Zatollah
GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (06) : 442 - 447

← 1 2 3 4 5 →